Current monitoring and treatment of progressive fibrosing interstitial lung disease: a survey of physicians in Japan, the United States, and the European Union

Author:

Takizawa Ayako1ORCID,Kamita Mitsutoyo1,Kondoh Yasuhiro2,Bando Masashi3,Kuwana Masataka4ORCID,Inoue Yoshikazu5ORCID

Affiliation:

1. Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan

2. Tosei General Hospital, Aichi, Japan

3. Jichi Medical University, Tochigi, Japan

4. Nippon Medical School, Tokyo, Japan

5. National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan

Publisher

Informa UK Limited

Subject

General Medicine

Reference58 articles.

1. Raghu G. Interstitial lung disease. Goldman’s Cecil Medicine. 25th ed. Philadelphia: Saunders; 2016. p. 575–588.

2. The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

3. Antoine M, Mlika M. Interstitial lung disease. StatPearls. Treasure Island (FL). 2020; [cited 2020 Dec 9]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31082128.

4. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3